Efforts to develop a gene therapy for Diamond-Blackfan anemia (DBA) — a rare, life-threatening disorder in which bone marrow ...

The new treatment is painful and expensive ... Last May, a 12-year-old with sickle cell anemia was the first person to receive a new gene therapy to treat the disease. The process is painful ...

Although not guideline-approved, screening for iron deficiency in patients with risk factors could prevent progression to ...

which boost the production of a person's own red blood cells, are better than relying on someone else's blood. Anemia is incredibly common, especially in surgical patients, and until recently the ...

Mississauga: GSK has announced that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or ...

The anti-malarial drug Artemisinin is highly effective. It's critical for kids, who are especially vulnerable. A new study ...

GSK announced today that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or ...

The life expectancy for people with MAHA ... the post-treatment mortality rate is 10% to 15%. What is the most common cause of hemolytic anemia? Scientists are uncertain about the most common ...

Treatment of sickle cell anemia includes ... blood pool in the spleen Other acute complications of sickle cell anemia Some people need blood transfusions only occasionally, while others need ...

Treatment involves addressing the underlying deficiency through dietary changes, supplementation, or medical interventions, aiming to restore normal red blood cell production and alleviate symptoms of ...

Uterine fibroids are a common condition that affects up to 80% of women in their lifetime. Nearly half of those women will ...